I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Cathepsin B Processing Is Required for the In Vivo Efficacy..:
Barbara Bernardim
;
João Conde
;
Tuuli Hakala
...
doi:10.1021/acs.bioconjchem.3c00478.s001. , 2024
Link:
https://doi.org/10.1021/acs.bioconjchem.3c00478.s001
RT Journal T1
Cathepsin B Processing Is Required for the In Vivo Efficacy of Albumin–Drug Conjugates
UL https://suche.suub.uni-bremen.de/peid=base-ftdeakinunifig:oai:figshare.com:article_25205942&Exemplar=1&LAN=DE A1 Barbara Bernardim A1 João Conde A1 Tuuli Hakala A1 Julie B. Becher A1 Mary Canzano A1 Aldrin V. Vasco A1 Tuomas P. J. Knowles A1 Jason Cameron A1 Gonçalo J. L. Bernardes YR 2024 K1 Biophysics K1 Biochemistry K1 Cell Biology K1 Molecular Biology K1 Pharmacology K1 Biotechnology K1 Immunology K1 Cancer K1 Computational Biology K1 Space Science K1 Chemical Sciences not elsewhere classified K1 valine – citrulline K1 selective antitumor activity K1 question whether protease K1 pronounced antitumor activity K1 preferable tumor biodistribution K1 potent antitumor activity K1 monomethyl auristatin e K1 effective pharmaceutical treatments K1 linker – payload K1 >)]- containing linker K1 plasma stable conjugates K1 human serum albumin K1 >)] linker K1 synthesized one K1 protease cleavable linkers K1 cathepsin b processing K1 retained fcrn binding K1 >)] linker K1 cathepsin b K1 albumin conjugates K1 enhanced binding K1 conjugates equipped K1 albumin using K1 vc (< K1 target delivery K1 specific tissues K1 solid tumors K1 side effects K1 results suggest K1 produced homogeneous K1 neonatal fc K1 mediated recycling K1 mediated cleavage K1 hbii ) K1 great interest K1 fragment crystallizable K1 findings demonstrate K1 engineered version K1 engineered albumins JF doi:10.1021/acs.bioconjchem.3c00478.s001 LK http://dx.doi.org/https://doi.org/10.1021/acs.bioconjchem.3c00478.s001 DO https://doi.org/10.1021/acs.bioconjchem.3c00478.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)